Subscribe To
Pliant therapeutics to participate in upcoming investor events
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focus...
February 7, 2023, 1:01 pm
Should investors buy or sell the vaccinex patent news?
Shares of Vaccinex, Inc. (NASDAQ: VCNX) are charging higher on February 7 on news that the clinical-stage biotechnology company secured a patent. VCNX...
February 7, 2023, 11:10 am
Empower clinics partners with nuclear medicine specialist to launch us clinical trial management services
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has entered into a letter of intent (LOI) with Dr Bharat Mocherla, a Nuclear Medicine Specialist i...
February 7, 2023, 9:54 am
Why is rubius therapeutics (ruby) stock down 16% today?
Rubius Therapeutics (NASDAQ: RUBY ) stock is falling hard on Tuesday after the biotechnology company received a Nasdaq delisting notice. According to ...
February 7, 2023, 8:46 am
Why is vaccinex (vcnx) stock up 67% today?
Vaccinex (NASDAQ: VCNX ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. Instead, it looks ...
February 7, 2023, 7:41 am
Is biotech immunocore about to make a 25% price move?
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceutica...
February 7, 2023, 7:00 am
Verona pharma: small biotech targeting $10bn copd market with a late stage drug
Verona Pharma is a UK-based biotech with a $1.6Bn market cap developing a phase 3 asset targeting COPD....
February 7, 2023, 6:01 am
Arvinas to participate in upcoming investor conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...
February 6, 2023, 9:30 pm
Arvinas to participate in upcoming investor conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...
February 6, 2023, 4:30 pm
Hillstream biopharma to host virtual r&d day to showcase its emerging immuno-oncology pipeline targeting drug-resistant cancers
Quatramer-based HSB-1216 combined with anti-MUC1-C antibody designed to target cancer stem cells (CSCs) by inducing ferroptosis in drug resistant canc...
February 6, 2023, 12:00 pm
Revive therapeutics secures supply of mdma from pharmaala biotech for transdermal patch development
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has entered into a supply agreement with PharmaAla biot...
February 6, 2023, 8:40 am
Idorsia: interesting swiss biotech, but commercialization seems uncertain
Idorsia is a Swiss biopharmaceutical company with multiple commercial and pre-commercial assets. Idorisa's lead asset Daridorexant seems to be a more ...
February 4, 2023, 6:06 am
Senti biosciences announces new employment inducement grants
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company inno...
February 3, 2023, 9:05 pm
Jasper therapeutics, inc. reports inducement grant under nasdaq listing rule 5635(c)(4)
REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
February 3, 2023, 9:05 pm
4 biotech stocks set to outpace q4 earnings estimates
Let us look at some biotech stocks, ALLO, EDIT, NTLA and SGEN that are poised to beat on fourth-quarter...
February 3, 2023, 3:48 pm
Ipo stock of the week: biotech leader immunocore approaches latest buy point
biotech leader Immunocore is just below its latest buy point ahead of quarterly earnings results. The p...
February 3, 2023, 2:58 pm
Alector: trading at cash despite late stage cns pipeline
Alector, Inc. has a lot of cash for a small biotech, but it is also trading at cash. Alector, Inc. has a late-stage program in a CNS indication and ma...
February 3, 2023, 2:13 pm
Why editas medicine's shares jumped this week
The gene-editing biotech's shares have had a strong two-week run....
February 3, 2023, 12:10 pm
Vyant bio commences a cash preservation plan including a reduction in force
Continuing to Explore Strategic Alternatives CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) ...
February 3, 2023, 11:00 am
Regeneron stock rallies after profit and revenue beat expectations by wide margins
Shares of Regeneron Pharmaceuticals Inc. REGN, -0.90% rallied 1.9% toward a two-month high in premarket trading Friday, after the biotechnology compan...
February 3, 2023, 6:45 am